Article Information
History
- October 10, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Anthony Bayega1,
- Sarah J. Reiling1,
- Isabelle Dubuc2,
- Annie Gravel2,
- Louis Flamand2,3 and
- Jiannis Ragoussis1,4,*
- 1McGill Genome Centre, Department of Human Genetics, McGill University, Montréal, Québec, Canada
- 2Division des maladies infectieuses et immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec - Université Laval, Quebec City, QC, Canada
- 3Département de microbiologie-infectiologie et d’immunologie, Faculté de médecine, Université Laval, Quebec City, QC, Canada
- 4Department of Bioengineering, McGill University, Montréal, Québec, Canada
- ↵*corresponding author ioannis.ragoussis{at}mcgill.ca
Posted October 10, 2024.
A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method
